Reducing antibiotic usage for acute respiratory infections by increasing guideline adherence including a wait-and-see prescription.
- Conditions
- upper respiratory tract infections bovenste luchtwegklachten
- Registration Number
- NL-OMON27789
- Lead Sponsor
- IVM (subsidized by ZonMw)
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 1600
Inclusion Criteria
1. All patients who consult their GP with URTI are in principal eligible to receive a wait-and-see prescription. Since, preferably, GPs should not prescribe antibiotics to patients with URTI, in practice only those patients for whom the GP thinks a WASP is an option will receive a WASP and only after discussing it with the patient (note: if the GP thinks the patient needs an antibiotic s/he will prescribe that antibiotic without discussing the principle of WASP). It is up to the GP to discuss a WASP with the patient and to decide whether or not to prescribe a WASP;
2. Patients of all ages will be included.
Exclusion Criteria
N/A
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome measure is the number of patients with URTI who filled their antibiotic prescription at the pharmacy in the 12 months before the first PTAM-meeting (pretest) and 12 months hereafter (posttest).
- Secondary Outcome Measures
Name Time Method 1. Cccurence of complications (e.g. bronchitis and pneumonia);<br /><br>2. Patients' judgement on the quality of care received for URTI.